Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis”
Meron Teklu, MD,
Hye Jin Chung, MD, MMSc
Affiliations
Meron Teklu, MD
Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Harvard Combined Dermatology Residency, Boston, Massachusetts
Hye Jin Chung, MD, MMSc
Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Correspondence to: Hye Jin Chung, MD, MMSc, Beth Israel Deaconess Medical Center, Department of Dermatology, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02115